Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | ASCO 2020: highlights in immuno-oncology

Heather McArthur • 3 Jun 2020
ASCO 2020
General

Heather McArthur, MD, MPH, of Cedars-Sinai Medical Center, Los Angeles, CA, discusses immuno-oncology highlights from ASCO 2020, including tumor vaccines as well as studies investigating combination treatment of checkpoint blockade with other targets such as OXO40 and LAG3 to increase the breadth of patients with durable responses. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Heather McArthur

2:05
TROPION-Breast04: Dato-DXd and durvalumab in TNBC or HR-low/HER2- breast cancer
Heather McArthur • 13 Dec 2023
1:56
Management of ER+ breast cancer with checkpoint inhibitors
Heather McArthur • 13 Dec 2023
1:37
How can we best sequence ADCs in breast cancer?
Heather McArthur • 13 Dec 2023
1:51
Managing ADC-related toxicity in breast cancer
Heather McArthur • 13 Dec 2023

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals